Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice the first side effects of Mounjaro within a few hours to two days of their initial injection — nausea is usually the earliest and most common signal. That timing can shift slightly with each dose increase. Mounjaro (tirzepatide) is a prescription-only medicine, and how you respond is something a prescriber reviews with you individually, not something any general guide can predict exactly. What this page covers is the pattern most people experience, what to watch for at each stage, and the symptoms that should prompt same-day medical attention.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
After your first 2.5 mg Mounjaro injection, tirzepatide begins slowing gastric emptying, the rate at which food moves out of your stomach. That physiological shift is quick. For many people, a low-level queasiness sets in within two to six hours, peaking in the first 24 hours and largely settling by 48 hours. Some people feel nothing at all from the first pen. Both responses are normal.
A common misconception worth clearing up gently: many people assume the nausea means the medicine is working harder, or that feeling nothing means it isn't working. Neither is true. Side-effect intensity at 2.5 mg tells you very little about how much weight you'll lose further along. The starter dose exists mainly to let your system acclimatise, not to produce a therapeutic effect, which is why prescribers don't judge progress on it. For a fuller picture of what Mounjaro actually does in the body, the Mounjaro overview page walks through the mechanism clearly.
The NHS tirzepatide medicines page lists nausea, vomiting, diarrhoea, constipation, indigestion, burping and fatigue as the most commonly reported effects. Injection-site redness or tenderness is also possible and usually settles within a day or two.
If the first few weeks passed relatively smoothly, it's easy to assume you're past the tricky part. You may not be. The pattern with tirzepatide is that side effects tend to resurface (or intensify) after each dose increase, then settle again before the next one. This cycle repeats from 2.5 mg through to whatever maintenance dose your prescriber lands on.
The 24–48 hour window after a new dose is the highest-risk period each time. Eating smaller portions before and after injecting, staying well hydrated, and avoiding high-fat or heavily spiced food on injection day are practical steps that many people find helpful, though your prescriber and the Patient Information Leaflet are the right reference for personal guidance on managing symptoms.
How long side effects last at each step varies. For most people, GI symptoms at a new dose settle within one to two weeks. If they don't, or if they are severe enough to affect daily life, that's a conversation for your prescriber rather than something to wait out quietly. Our page on Mounjaro side effects covers the full profile in more detail, including what tends to improve and what to flag.
For a close look at how quickly effects tend to kick in on each pen, this page on early timing and this one on duration go deeper on both questions.
Nausea that comes and goes is expected. The following are not, and each warrants same-day medical attention or, in severe cases, calling 999 or going to A&E:
Severe, persistent stomach pain, especially pain that spreads to the back. This may indicate acute pancreatitis, a known but uncommon side effect of GLP-1 medicines. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting pancreatitis risk with this class of medicines, the symptom to act on is pain that is severe and doesn't pass, with or without vomiting. Do not attribute this to ordinary nausea and wait it out.
Signs of dehydration (dizziness, dark urine, very little urination) can follow severe vomiting or diarrhoea and can affect kidney function. If you can't keep fluids down for more than 24 hours, contact a healthcare professional.
Symptoms of a serious allergic reaction: swelling of the face, lips or throat, difficulty breathing, rapid heartbeat. Stop the medicine and seek emergency help.
Gallbladder-related pain (upper right abdomen, sometimes after eating) and unexplained changes in mood or thoughts of self-harm should also be discussed with a clinician promptly. The Yellow Card scheme at yellowcard.mhra.gov.uk allows patients to report any suspected side effect directly to the MHRA, doing so helps build the UK safety record for newer medicines like tirzepatide, which still carries a Black Triangle (▼) status.
The decision to push through manageable side effects, slow the titration, or stop altogether is a clinical one. That said, the information that helps make it is straightforward: how severe are the symptoms, how long have they lasted, and are they affecting your ability to eat, drink and function day to day?
Mild nausea that settles by day two is very different from vomiting that persists into the following week. Your prescriber can slow the titration schedule, which often reduces the severity considerably, the path from 2.5 mg to a higher dose doesn't have to follow a rigid timetable if your body needs longer. Questions about how long the sickness lasts and when to expect it come up often, and having clear answers before you start a new dose makes the experience less alarming.
At nume, our prescribers discuss likely side effects, their timing and how to manage them as part of the consultation, before any prescription is issued. If you're weighing up whether treatment is right for you, starting a free consultation is the place to begin that conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.